Skip to the page

Data / Drug companies / Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.

Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.: 14 products in the FDA NDC directory, labeler code 64025

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. (labeler code 64025) lists 14 products in the FDA National Drug Code Directory. By type: 14 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 15, 2023.

The request: Watch Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. (FDA labeler code 64025): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
64025
Products in commercial distribution
14
Packages
43
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule III 7
Started marketing in the last 12 months
0
Earliest marketing start
March 4, 2005
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients14100%

Products by type

TypeProductsShare
Bulk ingredients14100%

Dosage forms

Dosage formProductsShare
Powder14100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Prasterone64025-0022PowderBulk ingredientsSeptember 15, 2023
Testosterone cypionate64025-0021PowderBulk ingredientsJanuary 2, 2014
Testosterone cypionate64025-0021PowderBulk ingredientsJanuary 2, 2014
Testosterone enanthate64025-0020PowderBulk ingredientsJanuary 2, 2014
Testosterone propionate64025-0019PowderBulk ingredientsJanuary 2, 2014
Testosterone propionate64025-0019PowderBulk ingredientsJanuary 2, 2014
Progesterone wettable64025-9802PowderBulk ingredientsDecember 1, 2009
7-oxo-prasterone64025-0770PowderBulk ingredientsDecember 1, 2009
Dehydroepiandrosterone64025-0015PowderBulk ingredientsDecember 1, 2009
Pregnenolone64025-0012PowderBulk ingredientsDecember 1, 2009
Testosterone64025-0010PowderBulk ingredientsDecember 1, 2009
Testosterone64025-0010PowderBulk ingredientsDecember 1, 2009
Progesterone64025-9801PowderBulk ingredientsDecember 8, 2007
Prasterone64025-0017PowderBulk ingredientsMarch 4, 2005

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.